I had some doubts about adding Danaher (DHR) to my Special Report: 10 picks for an earnings recession. Did the stock have enough of a catalyst to carry it upward during the slowdown in earnings predicted for at least the first three quarters of 2019? Yes, the company was selling off its dental unit, which […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
